Opportunity Information: Apply for EP IDS 14 013
Apply for EP IDS 14 013
- The Assistant Secretary for Preparedness and Response in the health sector is offering a public funding opportunity titled "Enhance global health security and advance International Health Regulations (2005)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.019 Technical Assistance and Provision for Foreign Hospitals and Health Organizations.
- This funding opportunity was created on Jul 24, 2014 and posted on Jul 23, 2014.
- Applicants must submit their applications by Aug 30, 2014 All applications must be submitted by August 30, 2014, 1159 p.m., Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below Pasteur Foundation.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Enhance global health security and advance International Health Regulations (2005)," was a U.S. government discretionary funding announcement designed to strengthen global health security by improving how selected countries prevent, detect, and respond to pandemic influenza and other emerging or re-emerging infectious diseases. The work was intended to directly support implementation of the International Health Regulations (IHR) (2005), which is the global framework that guides countries in building core public health capacities for surveillance, laboratory diagnostics, reporting, and emergency response. The focus countries named in the announcement were Senegal, Cameroon, Ivory Coast, Madagascar, the Central African Republic (CAR), and Cambodia, reflecting an emphasis on building and sustaining preparedness and response capacity in settings where stronger systems can significantly reduce regional and international health risks.
The announcement emphasized practical, system-level improvements rather than standalone projects. Funded activities were expected to sustain and strengthen existing preparedness, detection, and emergency communications capabilities, particularly those associated with pandemic influenza, while ensuring that the same capacities could be applied to other infectious disease threats and broader public health emergencies. Key areas highlighted included improving detection and diagnosis (especially through laboratory capacity), strengthening surveillance and reporting systems, and enhancing emergency communications so that alerts and situational awareness can move quickly between local, national, and regional partners. In other words, the program aimed to make routine surveillance and outbreak response more reliable day-to-day, and also more scalable during a major event.
A central expectation was that proposed projects would build upon and extend existing infectious disease surveillance and response systems rather than create parallel structures. This included investments in laboratory infrastructure and capabilities, as well as other public health infrastructure improvements that support the IHR (2005) core capacities. The FOA also stressed the importance of regional and national partnerships, implying that coordination across ministries, national public health institutes, laboratories, and international networks would be an important feature of successful proposals. The overall intent was to strengthen the end-to-end pathway from identifying a suspicious health event, to confirming it through diagnostics, to reporting it rapidly, to communicating risk and coordinating response actions.
From an administrative standpoint, this opportunity was issued as a cooperative agreement, which typically means the funding agency anticipated substantial involvement during program implementation (for example, coordination, technical input, or joint planning). The issuing agency was the Assistant Secretary for Preparedness and Response (ASPR), and the activity category was Health. The CFDA number listed was 93.019, described as technical assistance and provision for foreign hospitals and health organizations. The opportunity did not require cost sharing or matching funds.
The funding range was relatively targeted: the award floor was $700,000 and the award ceiling was $1,000,000. The opportunity was posted July 23, 2014 (created July 24, 2014) and had a single application deadline of August 30, 2014, by 11:59 p.m. Eastern Standard Time. It was later archived on September 29, 2014. Eligibility was restricted; the announcement indicated eligible applicants under "Others" and specifically listed the Pasteur Foundation in the eligibility information, suggesting a limited competition or a specialized eligibility scope tied to institutional capacity and established networks.
For applicants needing support accessing or submitting the full announcement, the contact point referenced was the Grants.gov Contact Center (1-800-518-4726, support@grants.gov), available around the clock except federal holidays. Overall, the opportunity was structured to fund coordinated, capacity-building work that measurably improves IHR (2005) core functions in the specified countries, with an emphasis on durable surveillance, laboratory diagnostics, timely reporting, and effective emergency communication for influenza and other high-consequence infectious threats.
Frequently Asked Questions (FAQs)
1) What is the title of this grant opportunity?
The opportunity is titled "Enhance global health security and advance International Health Regulations (2005)."
2) What is the main purpose of the funding?
The purpose is to strengthen global health security by improving how selected countries prevent, detect, and respond to pandemic influenza and other emerging or re-emerging infectious diseases, while directly supporting implementation of the International Health Regulations (IHR) (2005).
3) What are the International Health Regulations (2005) and how does this opportunity relate to them?
The IHR (2005) are a global framework guiding countries in building core public health capacities, including surveillance, laboratory diagnostics, reporting, and emergency response. This funding opportunity was intended to support and advance those core capacities in practice.
4) Which countries were specifically named as the focus of this announcement?
The announcement named Senegal, Cameroon, Ivory Coast, Madagascar, the Central African Republic (CAR), and Cambodia.
5) What types of health threats were emphasized?
The announcement emphasized pandemic influenza and other emerging or re-emerging infectious diseases, with an expectation that strengthened capacities would also be usable for broader public health emergencies.
6) What kinds of activities were expected to be supported?
Funded activities were expected to sustain and strengthen existing preparedness, detection, and emergency communications capabilities. Key areas highlighted included improving detection and diagnosis (particularly laboratory capacity), strengthening surveillance and reporting systems, and enhancing emergency communications to support fast alerts and situational awareness among partners.
7) Was the program focused on standalone projects or broader system improvements?
The announcement emphasized practical, system-level improvements rather than standalone projects, aiming to make routine surveillance and outbreak response more reliable day-to-day and more scalable during major events.
8) Did proposals need to build on existing systems?
Yes. A central expectation was that proposed work would build upon and extend existing infectious disease surveillance and response systems rather than create parallel structures.
9) What role did laboratories play in the expected program activities?
Laboratory capacity was a highlighted priority area, including improvements to detection and diagnosis and investments in laboratory infrastructure and capabilities as part of strengthening IHR (2005) core capacities.
10) What is meant by strengthening the "end-to-end pathway" for outbreak response?
The intent was to strengthen the full sequence from identifying a suspicious health event, to confirming it through diagnostics, to reporting it rapidly, to communicating risk, and coordinating response actions.
11) Were partnerships and coordination emphasized?
Yes. The FOA stressed the importance of regional and national partnerships and implied coordination across ministries, national public health institutes, laboratories, and international networks as an important feature of successful proposals.
12) What type of award mechanism was used?
This opportunity was issued as a cooperative agreement.
13) What does it mean that this was a cooperative agreement?
A cooperative agreement typically means the funding agency anticipated substantial involvement during implementation, such as coordination, technical input, or joint planning.
14) Which U.S. government office issued the opportunity?
The issuing agency was the Assistant Secretary for Preparedness and Response (ASPR).
15) What was the activity category?
The activity category listed was Health.
16) What CFDA number was associated with this opportunity?
The CFDA number listed was 93.019, described as technical assistance and provision for foreign hospitals and health organizations.
17) Was cost sharing or matching required?
No. The opportunity did not require cost sharing or matching funds.
18) What was the funding range for awards?
The award floor was $700,000 and the award ceiling was $1,000,000.
19) When was the opportunity posted and when was it created?
The opportunity was posted on July 23, 2014, and created on July 24, 2014.
20) What was the application deadline?
There was a single application deadline of August 30, 2014, by 11:59 p.m. Eastern Standard Time.
21) Is this opportunity still open?
No. The opportunity was archived on September 29, 2014.
22) Who was eligible to apply?
Eligibility was restricted. The announcement indicated eligible applicants under "Others" and specifically listed the Pasteur Foundation in the eligibility information, suggesting a limited competition or specialized eligibility scope tied to institutional capacity and established networks.
23) Where could applicants get help with accessing or submitting the announcement?
Applicants were directed to the Grants.gov Contact Center at 1-800-518-4726 or support@grants.gov. The contact center was described as available around the clock except federal holidays.
Browse more opportunities from the same category: Health
Next opportunity: Improve Parks Through Community Engagement
Previous opportunity: FA BLM New Mexico Socorro and Catron County Integrated Weed Management Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for EP IDS 14 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (EP IDS 14 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIH Transformative Research Awards (R01) Apply for RFA RM 14 003 Funding Number: RFA RM 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $15,000,000 |
| Enhance global health security and support International Health Regulations (2005) Apply for EP IDS 14 012 Funding Number: EP IDS 14 012 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $120,000 |
| Bioreactors for Reparative Medicine SBIR Direct Phase II (R44) Apply for RFA HL 15 017 Funding Number: RFA HL 15 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Bioreactors for Reparative Medicine (R41/R42) Apply for RFA HL 15 004 Funding Number: RFA HL 15 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bioreactors for Reparative Medicine (R43/R44) Apply for RFA HL 15 008 Funding Number: RFA HL 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Clinical Scientist Development Award in Aging (K08) Apply for RFA AG 15 016 Funding Number: RFA AG 15 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Patient Oriented Research Career Development Award in Aging (K23) Apply for RFA AG 15 017 Funding Number: RFA AG 15 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Clinical Studies on the Path to 510(k) (UH2/UH3) Apply for PAR 14 295 Funding Number: PAR 14 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Clinical Studies on the Path to 510(k) (U44) Apply for PAR 14 296 Funding Number: PAR 14 296 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Clinical Studies to Inform Final Device Design (UH2/UH3) Apply for PAR 14 297 Funding Number: PAR 14 297 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Early Feasibility Studies on the Path to Pre Market Approval (PMA) or Humanitarian Device Exemption (HDE) (UH2/UH3) Apply for PAR 14 298 Funding Number: PAR 14 298 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Early Feasibility Studies on the Path to Pre Market Approval (PMA) or Humanitarian Device Exemption (HDE) (U44) Apply for PAR 14 299 Funding Number: PAR 14 299 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS CREATE Devices Translational and Clinical Studies to Inform Final Device Design (U44) Apply for PAR 14 300 Funding Number: PAR 14 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Detect, Define and Measure the Progression of Chronic Traumatic Encephalopathy (U01) Apply for RFA NS 14 012 Funding Number: RFA NS 14 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhance global health security and implementation of International Health Regulations. Apply for EP IDS 14 014 Funding Number: EP IDS 14 014 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $350,000 |
| Office of Tribal Self Governance Program Planning Cooperative Agreement Apply for HHS 2014 IHS TSGP 0001 Funding Number: HHS 2014 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $120,000 |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS15 1504 Funding Number: CDC RFA PS15 1504 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Enhancing Cross National Research within the Health and Retirement Study Family of Studies (R01) Apply for RFA AG 15 015 Funding Number: RFA AG 15 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 14 302 Funding Number: PAR 14 302 Agency: National Institutes of Health Category: Health Funding Amount: $249,000 |
| The NIGMS Human Genetic Cell Repository (U42) Apply for RFA GM 15 005 Funding Number: RFA GM 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $2,800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "EP IDS 14 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.